ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 363143 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 363143; 2) Community: the network communities that were significantly associated with the response to NSC 363143; 3) Molecule: the relationships between components within communities and NSC 363143; 4) MDR: the compounds that were significantly associated with the NSC 363143.

NSC Compound Enrichment Correlation
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.000880521445136057 0.48129178
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.000880521445136057 0.64379757
NSC 666667 Null 0.000880521445136057 0.47595484
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.000944238008110124 0.63548531
NSC 668259 Null 0.000944238008110124 0.57415274
NSC 401268 Bergaptenquinone 0.00126952303154153 0.32955197
NSC 619677 Null 0.00126952303154153 0.59424366
NSC 656208 Null 0.00126952303154153 0.46799655
NSC 681229 Boronic acid, [1-[[2-amino-3-(1-naphthalenyl)- 1-oxopropyl]amino]-3-methylbutyl]-, L-(S)-, hydrochloride 0.00126952303154153 0.37147135
NSC 684569 Barbituric acid, 5-[3-(4-methoxyphenyl)- 2-propenylidene]-2-thio- 0.00126952303154153 0.48619264
Total:77  Current:4    [First] [Prev] [Next] [Last]